Brett Matthew Hall - 10 Feb 2022 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
CHIEF SCIENTIFIC OFFICER
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Brett Matthew Hall
Issuer symbol
IMRX
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 16:33:53 UTC
Previous filing
22 Dec 2021
Next filing
23 Mar 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +83,100 $0.000000 83,100 10 Feb 2022 Class A Common Stock 83,100 $9.66 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2022, and will be fully vested and exercisable on January 1, 2026.